IMD Natural Solutions Receives €4 Million Equity Investment from Zhejiang Hisun Pharmaceutical Co., Ltd.
IMD Natural Solutions GmbH (INS) announced a collaboration with Zhejiang Hisun Pharmaceutical Co., Ltd. under which INS receives a €4 million equity investment and provides Hisun access to INS’ unique natural product lead discovery platform for antimicrobials and antioxidants for the food, beverage and personal care industries. Furthermore, INS will benefit from Hisun’s production know-how and capabilities.
The investment paves the way for INS to further develop and commercialize its antimicrobial preservation product for use in food, beverage and personal care applications. It is a fermentation-based all-natural agent with superior efficacy against yeasts, molds and other microbial strains and has shown bioactivity against microbial organisms that have adapted to current preservative agents. The collaboration provides Hisun access to INS’ natural product databases and technology for the identification and development of suitable active natural ingredients for various life science applications.
“The investment by Hisun into INS and our access to Hisun’s production know-how and capabilities are an important step in driving our core product towards market entry,” said Dr. Thomas Henkel, Managing Director of INS.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
